X4 Pharmaceuticals (XFOR) Other Gross PP&E Adjustments (2018 - 2025)
X4 Pharmaceuticals (XFOR) has disclosed Other Gross PP&E Adjustments for 8 consecutive years, with -$1.8 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Other Gross PP&E Adjustments rose 12.17% year-over-year to -$1.8 million, compared with a TTM value of -$1.8 million through Sep 2025, up 12.17%, and an annual FY2024 reading of -$1.4 million, up 57.82% over the prior year.
- Other Gross PP&E Adjustments was -$1.8 million for Q3 2025 at X4 Pharmaceuticals, down from -$1.2 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at -$1.2 million in Q2 2025 and bottomed at -$7.6 million in Q1 2021.
- Average Other Gross PP&E Adjustments over 5 years is -$4.2 million, with a median of -$4.1 million recorded in 2023.
- The sharpest move saw Other Gross PP&E Adjustments crashed 737.34% in 2021, then soared 57.82% in 2024.
- Year by year, Other Gross PP&E Adjustments stood at -$6.5 million in 2021, then grew by 24.34% to -$4.9 million in 2022, then surged by 32.9% to -$3.3 million in 2023, then skyrocketed by 57.82% to -$1.4 million in 2024, then decreased by 28.07% to -$1.8 million in 2025.
- Business Quant data shows Other Gross PP&E Adjustments for XFOR at -$1.8 million in Q3 2025, -$1.2 million in Q2 2025, and -$1.5 million in Q1 2025.